Low nuclear CYP2W1 was significantly associated with adverse breast cancer specific survival (p = 0.012), with significance also maintained in multivariate analysis (HR: 0.677; 95% CI: 0.510–0.898; p = 0.007). The gene discussed is CYP2W1; the disease is breast cancer.